Latest AI and machine learning research in skin cancer for healthcare professionals.
Cancer remains one of the most challenging diseases to conquer due to its high mortality rate and the lack of effective diagnostic and therapeutic tools. Microrobot technology has brought revolutionary advancements to the field of tumor medicine. By leveraging its micro/nanoscale dimensions and precise propulsion and navigation capabilities, it has enhanced the accuracy and efficiency of cancer di...
BACKGROUND: Smooth muscle (SM) invasion represents a critical feature of prostate cancer (PCa) progression and metastasis. This study aimed to develop a SM-based molecular score for progression and metastasis forecasting for PCa. PATIENTS AND METHODS: A total of 952 patients with PCa with transcriptomic sequencing data and corresponding clinical information were included in this study to develop a...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense stroma and dysfunctional vasculature, limiting drug delivery and immune infiltrati...
Deep learning (DL) models have shown promise in predicting molecular alterations directly from hematoxylin and eosin-stained whole slide images in a v...
Microsatellite instability (MSI) has gained increasing attention as a promising biomarker for cancer immunotherapy in diverse cancer types. As a resul...
Immune checkpoint inhibitors have partially improved treatment outcomes for patients with head and neck squamous cell carcinoma (HNSCC), but the respo...
Epigenetic macromolecular enzyme complexes tightly regulate gene expression at the chromatin level and have recently been found to colocalize with RNA...
The tumor immune microenvironment (TIME) critically impacts cancer progression and immunotherapy response. Multiplex immunofluorescence (mIF) is a pow...
INTRODUCTION: The global incidence of skin cancer is rising, emphasizing the need for early detection tools. Artificial intelligence (AI) models, incl...
With the advent of novel cancer treatment options such as immunotherapy, studying the tumour immune micro-environment (TIME) is crucial to inform on p...
The human microbiome, encompassing microbial communities in the gut and breast tissue, has emerged as a critical modulator of breast cancer (BC) initi...
BACKGROUND: Lactylation is acknowledged as a regulator of numerous biological processes related to cancer. Research on the ability of lactylation-rela...
Lung cancer's metastatic propensity and recurrence prevalence necessitate innovative immunotherapy strategies beyond conventional single-mode regulati...
OBJECTIVE: Current systematic literature reviews largely rely on manual screening of articles retrieved through keyword search, which is time-consumin...
Cancer remains one of the most biologically intricate and heterogeneous diseases, with variability spanning genetic, epigenetic, metabolic, spatial, a...
OBJECTIVES: To develop and evaluate the predictive efficacy of a combined model incorporating clinical parameters and PET-based radiomics signature (R...
Cancer is a disease that begins with genetic and epigenetic alterations occurring in specific cells, some of which can spread and migrate to other tis...
Lung adenocarcinoma (LUAD) is the most common histological type of lung cancer, characterized by high mortality, recurrence, and metastasis. Despite a...
The growing number of cancer cases and deaths highlights the urgent need for innovative treatment approaches. One technique that has lately been recog...